Eli Lilly has appointed key appointments to its senior management team after the retirements of Bryce D. Carmine, Senior Vice President and President of Lilly Bio-Medicines, and Frank Deane, President of Manufacturing Operations (both pictured below).
The two will step down at the end of the year with Dave Ricks, President of Lilly USA, replacing Mr Carmine and Maria Crowe, Senior Vice President for Global Drug Product Manufacturing, succeeding Mr Deane.
John C. Lechleiter, Chairman, President, and CEO, Lilly, says the outgoing pair have been “pillars of the company who have had a lasting, worldwide impact”.
Mr Deane, who has let the Bio-Medicines division since 2009, and Mr Carmine, the leader of global manufacturing since 2007, have a combined 69 years of experience at the company.
“We’re grateful for their dedicated service,” said Mr Lechleiter. “We’ll certainly miss Bryce and Frank and the extraordinary leadership they provided.
“At the same time, we’re very fortunate to have talented leaders who are well-prepared and ready to step into these critical roles.”
As a result of Mr Ricks’ promotion, Alex Azaz is being promoted to President of Lilly USA.